Total Payments
$1,273
2024 Payments
$330.22
Companies
12
Transactions
55
Medicare Patients
1,374
Medicare Billing
$129,437
Payment Breakdown by Category
Food & Beverage$1,174 (92.2%)
Education$99.00 (7.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,174 | 54 | 92.2% |
| Education | $99.00 | 1 | 7.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $315.44 | 12 | $0 (2024) |
| Celgene Corporation | $263.96 | 19 | $0 (2024) |
| PFIZER INC. | $167.92 | 3 | $0 (2024) |
| ABBVIE INC. | $157.05 | 9 | $0 (2024) |
| AIMMUNE THERAPEUTICS, INC. | $124.99 | 1 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $61.36 | 3 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $55.59 | 3 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $41.17 | 1 | $0 (2023) |
| Covidien LP | $29.48 | 1 | $0 (2019) |
| Mauna Kea Technologies, Inc. | $25.68 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $330.22 | 11 | AIMMUNE THERAPEUTICS, INC. ($124.99) |
| 2023 | $499.31 | 28 | Janssen Biotech, Inc. ($187.01) |
| 2022 | $177.40 | 8 | Janssen Biotech, Inc. ($106.25) |
| 2021 | $68.82 | 3 | Celgene Corporation ($43.14) |
| 2019 | $182.60 | 4 | PFIZER INC. ($117.49) |
| 2017 | $14.53 | 1 | Gilead Sciences Inc ($14.53) |
All Payment Transactions
55 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/19/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 05/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/28/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 05/14/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: Immunology | ||||||
| 05/08/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $26.76 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 05/08/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.04 | General |
| Category: Neuroscience | ||||||
| 05/06/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ, HUMIRA | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: IMMUNOLOGY | ||||||
| 04/19/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ, HUMIRA | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: IMMUNOLOGY | ||||||
| 04/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: IMMUNOLOGY | ||||||
| 03/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: IMMUNOLOGY | ||||||
| 02/08/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $21.14 | General |
| Category: Neuroscience | ||||||
| 12/13/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: Immunology | ||||||
| 11/29/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $10.59 | General |
| Category: Neuroscience | ||||||
| 11/14/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $12.03 | General |
| Category: Neuroscience | ||||||
| 11/13/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $41.17 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/08/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $20.27 | General |
| Category: Neuroscience | ||||||
| 10/11/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/04/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $20.90 | General |
| Category: Neuroscience | ||||||
| 09/29/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $10.78 | General |
| Category: Neuroscience | ||||||
| 09/02/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 08/29/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $6.24 | General |
| Category: Immunology | ||||||
| 08/11/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $7.67 | General |
| Category: Immunology | ||||||
| 08/08/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $6.47 | General |
| Category: Neuroscience | ||||||
| 08/08/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $0.55 | General |
| Category: Neuroscience | ||||||
| 07/26/2023 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 521 | 576 | $201,294 | $42,227 |
| 2022 | 10 | 234 | 246 | $100,119 | $25,677 |
| 2021 | 11 | 294 | 307 | $138,821 | $30,378 |
| 2020 | 11 | 325 | 344 | $150,956 | $31,155 |
Total Patients
1,374
Total Services
1,473
Medicare Billing
$129,437
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 109 | 109 | $39,131 | $12,466 | 31.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 23 | 23 | $30,728 | $6,499 | 21.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 32 | 32 | $42,752 | $4,221 | 9.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 37 | $8,473 | $3,022 | 35.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 16 | 16 | $15,616 | $2,710 | 17.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 34 | 34 | $33,184 | $2,485 | 7.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 39 | $5,889 | $2,401 | 40.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 30 | 50 | $4,150 | $1,949 | 47.0% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 26 | 26 | $5,694 | $1,668 | 29.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $3,835 | $1,321 | 34.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $3,055 | $993.26 | 32.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 16 | $2,512 | $922.28 | 36.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 38 | 43 | $860.00 | $361.20 | 42.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 18 | 18 | $1,548 | $296.28 | 19.1% |
| 86258 | Detection of gliadin (deamidated) (dgp) antibody | Office | 2023 | 11 | 22 | $770.00 | $259.82 | 33.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 21 | 21 | $1,155 | $217.35 | 18.8% |
| 86364 | Measurement of tissue transglutaminase | Office | 2023 | 12 | 13 | $455.00 | $146.90 | 32.3% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 17 | 17 | $561.00 | $107.78 | 19.2% |
| 83690 | Lipase (fat enzyme) level | Office | 2023 | 12 | 12 | $420.00 | $81.00 | 19.3% |
| 82565 | Blood creatinine level | Office | 2023 | 11 | 11 | $286.00 | $55.22 | 19.3% |
| 84520 | Urea nitrogen level to assess kidney function, quantitative | Office | 2023 | 11 | 11 | $220.00 | $42.57 | 19.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 35 | 36 | $12,060 | $6,019 | 49.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 34 | 34 | $11,450 | $4,794 | 41.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 27 | 27 | $31,116 | $3,513 | 11.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 32 | 32 | $26,696 | $2,731 | 10.2% |
About Dr. Jennie Ng, M.D
Dr. Jennie Ng, M.D is a Gastroenterology healthcare provider based in Oakbrook Terrace, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1063599744.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jennie Ng, M.D has received a total of $1,273 in payments from pharmaceutical and medical device companies, with $330.22 received in 2024. These payments were reported across 55 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,174).
As a Medicare-enrolled provider, Ng has provided services to 1,374 Medicare beneficiaries, totaling 1,473 services with total Medicare billing of $129,437. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Oakbrook Terrace, IL
- Active Since 11/01/2006
- Last Updated 08/16/2023
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1063599744
Products in Payments
- STELARA (Biological) $309.20
- ZEPOSIA (Drug) $242.85
- XELJANZ (Drug) $167.92
- ZENPEP (Drug) $124.99
- SKYRIZI (Biological) $72.32
- RINVOQ (Biological) $68.04
- ENTYVIO (Biological) $41.38
- DUPIXENT (Biological) $41.17
- TRULANCE (Drug) $39.94
- Barrx (Device) $29.48
- XIFAXAN (Drug) $21.42
- LINZESS (Drug) $16.69
- Hulio (Drug) $15.71
- Entyvio (Biological) $14.21
- REMICADE (Biological) $6.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Oakbrook Terrace
Dr. David Chua, Md, MD
Gastroenterology — Payments: $12,058
Gastroenterology $12,058
Dr. Matthew Smith, M.d, M.D
Gastroenterology — Payments: $1,566
Gastroenterology $1,566
Dr. Dhruva Tilwalli, Md, MD
Gastroenterology — Payments: $543.23
Gastroenterology $543.23
Dr. Stephen Grill, M.d, M.D
Gastroenterology
Gastroenterology